New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Neurology

• Publication date

  2006-12-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/01.wnl.0000247064.53130.91PMID 17159103
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Salivary Cortisol, a Biological Marker of Stress, Is Positively Associated with 24-Hour Systolic Blood Pressure in Patients with Acute Ischaemic Stroke

  2004cited by this paper
• Blood Pressure Decrease During the Acute Phase of Ischemic Stroke Is Associated With Brain Injury and Poor Stroke Outcome

  2004cited by this paper
• Serum-cortisol reflects severity and mortality in acute stroke.

  2004cited by this paper
• Modulation of the Inflammatory Response in Cardiovascular Disease

  2004cited by this paper
• High blood pressure in acute stroke and subsequent outcome: a systematic review.

  2004cited by this paper
• C-Reactive Protein Upregulates Angiotensin Type 1 Receptors in Vascular Smooth Muscle

  2003cited by this paper
• The release of tumor necrosis factor-alpha is associated with ischemic tolerance in human stroke.

  2003cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

  2003cited by this paper
• Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association

  2003cited by this paper
• Effect of Blood Pressure During the Acute Period of Ischemic Stroke on Stroke Outcome: A Tertiary Analysis of the GAIN International Trial

  2003cited by this paper
• Altered cerebral vasoregulation in hypertension and stroke

  2003cited by this paper
• Management of acute ischaemic stroke: new guidelines from the American Stroke Association and European Stroke Initiative.

  2003cited by this paper
• Hypertension in acute ischemic stroke: a compensatory mechanism or an additional damaging factor?

  2003cited by this paper
• C-reactive protein and the risk of developing hypertension.

  2003cited by this paper
• Hypertension, matrix metalloproteinases and target organ damage.

  2003cited by this paper
• The release of tumor necrosis factor–α is associated with ischemic tolerance in human stroke

  2003cited by this paper
• Vascular inflammation and the renin-angiotensin system.

  2002cited by this paper
• Endothelin Antagonism and Interleukin-6 Inhibition Attenuate the Proatherogenic Effects of C-Reactive Protein

  2002cited by this paper
• Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.

  2002cited by this paper
• Blood Pressure Increase and Incidence of Hypertension in Relation to Inflammation-Sensitive Plasma Proteins

  2002cited by this paper
• Blood Pressure and Clinical Outcomes in the International Stroke Trial

  2002cited by this paper
• Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events*

  2002cited by this paper
• Long-Term Effects of Inflammation-Sensitive Plasma Proteins and Systolic Blood Pressure on Incidence of Stroke

  2002cited by this paper
• Interrelationships Among Circulating Interleukin-6, C-Reactive Protein, and Traditional Cardiovascular Risk Factors in Women

  2002cited by this paper
• Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells

  2002cited by this paper
• Elevated midlife blood pressure increases stroke risk in elderly persons: the Framingham Study.

  2001cited by this paper
• Blood Pressure and Inflammation in Apparently Healthy Men

  2001cited by this paper
• Is C-reactive protein an independent risk factor for essential hypertension?

  2001cited by this paper
• Proinflammatory Cytokines and Early Neurological Worsening in Ischemic Stroke

  2000cited by this paper
• Proinflammatory Cytokines and Early Neurological Worsening in Ischemic Stroke

  2000cited by this paper
• Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction: findings from National Health and Nutrition Examination Survey III.

  2000cited by this paper
• European Stroke Initiative Recommendations for Stroke Management

  2000cited by this paper
• Blood pressure and functional recovery in acute ischemic stroke.

  1998cited by this paper
• The validity of self-reported hypertension and correlates of hypertension awareness among blacks and whites within the stroke belt.

  1995cited by this paper
• Factors Affecting Changes in Blood Pressure After Acute Stroke

  1994cited by this paper
• Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial

  1993cited by this paper
• The Canadian Neurological Scale

  1989cited by this paper
• Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women.

  1986cited by this paper

• Large vessel occlusion mediated fluid attenuated inversion recovery signal intensity ratio is associated with stroke within 4.5 h

  2024cites this paper
• Inhibition of matrix metalloproteinases to reduce blood brain barrier disruption and haemorrhagic transformation in ischaemic stroke: go broad or go narrow?

  2024cites this paper
• Correlation Between MMP9 Promoter Methylation and Transient Ischemic Attack/Mild Ischemic Stroke with Early Cognitive Impairment

  2023cites this paper
• Frequency of Severely Elevated Blood Pressure on Admission in Known Hypertensive Patients Presenting with Acute Haemorrhagic Stroke

  2023cites this paper
• FREQUENCY OF SEVERELY ELEVATED BLOOD PRESSURE ON ADMISSION IN KNOWN HYPERTENSIVE PATIENTS PRESENTING WITH ACUTE HAEMORRHAGIC STROKE

  2022cites this paper
• Peripheral Blood Gene Expression at 3 to 24 Hours Correlates with and Predicts 90-Day Outcome Following Human Ischemic Stroke

  2022cites this paper
• Biomarkers Predictive of Long-Term Outcome After Ischemic Stroke: A Meta-Analysis.

  2021cites this paper
• Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke.

  2021cites this paper
• Biomarkers of Angiogenesis and Neuroplasticity as Promising Clinical Tools for Stroke Recovery Evaluation

  2021cites this paper
• Immune-inflammatory, coagulation, adhesion, and imaging biomarkers combined in machine learning models improve the prediction of death 1 year after ischemic stroke

  2021cites this paper
• Stroke prevention in patients with arterial hypertension: Recommendations of the Spanish Society of Neurology's Stroke Study Group.

  2021cites this paper
• Stroke Prognosis: Monitoring the Hemodynamics and Blood Pressure by TCD/TCCS

  2021cites this paper
• Matrix metalloproteinase-9 as a messenger in the cross talk between obstructive sleep apnea and comorbid systemic hypertension, cardiac remodeling, and ischemic stroke: a literature review

  2020cites this paper
• Association of Matrix Metalloproteinase 9 and Cellular Fibronectin and Outcome in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis

  2020cites this paper
• Association between serum matrix metalloproteinase-9 and poor prognosis in acute ischemic stroke patients: The role of dyslipidemia.

  2020cites this paper
• Prevención de ictus en pacientes con hipertensión arterial: recomendaciones del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología

  2020cites this paper
• Evaluation of inflammatory markers and mean platelet volume as short-term outcome indicators in young adults with ischemic stroke

  2019cites this paper
• Serum level of macrophage migration inhibitory factor predicts severity and prognosis in patients with ischemic stroke

  2019cites this paper
• Management of Blood Pressure After Acute Ischemic Stroke

  2019cites this paper
• Plasma levels of matrix metalloproteinase-9: A possible marker for cold-induced stroke risk in hypertensive rats.

  2019cites this paper
• The neuroprotective effects of Quercetin on hypoxic-ischemic brain injury in neonatal mice

  2019cites this paper
• Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management

  2018cites this paper
• The role of the lectin-like oxLDL receptor (LOX-1) in traffic-generated air pollution exposure-mediated alteration of the brain microvasculature in Apolipoprotein (Apo) E knockout mice

  2017cites this paper
• Role of Brain Biomarker in Predicting Clinical Outcome in Hypertensive Cerebrovascular Ischemic Stroke

  2017cites this paper
• Correlation study between small vessel disease and early neurological deterioration in patients with mild/moderate acute ischemic stroke

  2017cites this paper
• The relationship of pro-inflammatory markers to vascular endothelial function after acute stroke

  2017cites this paper
• Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke

  2017cites this paper
• Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke

  2016cites this paper
• Blood/Brain Biomarkers of Inflammation After Stroke and Their Association With Outcome: From C-Reactive Protein to Damage-Associated Molecular Patterns

  2016cites this paper
• Impact of Collaterals on Successful Revascularization in Solitaire FR With the Intention for Thrombectomy

  2014cites this paper
• Early treatment of hypertension in acute ischemic and intracerebral hemorrhagic stroke: progress achieved, challenges, and perspectives.

  2014cites this paper
• Management of hypertension in stroke.

  2014cites this paper
• HbA1c is associated with increased all-cause mortality in the first year after acute ischemic stroke

  2014cites this paper
• Prognostic value of blood interleukin-6 in the prediction of functional outcome after stroke: a systematic review and meta-analysis.

  2014cites this paper
• Study of Relationship Between High Blood Pressure and Clinical Markers and Individual Cerebro Vascular Accident in Clients that Referred to Towhid Hospital in Sanandaj(Kurdistan of Iran) in 2010

  2013cites this paper
• Low Serum n-3 Polyunsaturated Fatty Acid/n-6 Polyunsaturated Fatty Acid Ratio Predicts Neurological Deterioration in Japanese Patients with Acute Ischemic Stroke

  2013cites this paper
• Blood microRNAs in Low or No Risk Ischemic Stroke Patients

  2013cites this paper
• Predictive value of circulating interleukin-6 and heart-type fatty acid binding protein for three months clinical outcome in acute cerebral infarction: multiple blood markers profiling study

  2013cites this paper
• Blood pressure lowering treatment in acute stroke

  2012cites this paper
• Spontaneously hypertensive rats display reduced microglial activation in response to ischemic stroke and lipopolysaccharide

  2012cites this paper
• Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review.

  2012cites this paper
• A biochemical marker panel in MRI-proven hyperacute ischemic stroke-a prospective study

  2012cites this paper
• Influence of temperature on ischemic brain: basic and clinical principles.

  2012cites this paper
• Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review.

  2011cites this paper
• Acute Blood Pressure Management After Ischemic Stroke

  2011cites this paper
• Reduced Cardiorespiratory Fitness after Stroke: Biological Consequences and Exercise-Induced Adaptations

  2011cites this paper
• Blood pressure management in acute stroke

  2009cites this paper
• Blood pressure as a prognostic factor after acute stroke.

  2009cites this paper
• Age Determines the Effects of Blood Pressure Lowering During the Acute Phase of Ischemic Stroke: The TICA Study

  2009cites this paper
• Management of hypertension in acute stroke

  2009cites this paper
• Correlation between interleukin-6 promoter and C-reactive protein (CRP) polymorphisms and CRP levels with the Mainz Severity Score Index for Fabry disease

  2008cites this paper
• Role of inflammatory markers in brain ischemia

  2008cites this paper
• Early changes in physiological variables after stroke

  2008cites this paper
• IL-6 as a biomarker of ischemic cerebrovascular disease.

  2008cites this paper
• Acute Hypertensive Response in Patients With Stroke: Pathophysiology and Management

  2008cites this paper